Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase describes the therapeutic effect of Photodynamic Therapy (PDT), a procedure where a photosensitizing drug is administered and preferentially accumulates in cancer cells and associated vasculature. Upon irradiation with light of a specific wavelength, the drug becomes activated, generating reactive oxygen species (mostly singlet oxygen). These ROS rapidly damage cellular membranes and the structural components of blood vessels within the tumor, leading to cell death, blockage of tumor blood supply, tumor hypoxia, and immune activation. This mechanism is utilized for localized cancer treatment, targeting both the tumor parenchyma and its supporting microvasculature, and is not a single molecular target but a multi-faceted biological response.
Generation of reactive oxygen species (ROS) upon photosensitizer activation by light Selective destruction of tumor cell membranes and tumor vasculature through oxidative damage
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor cell membrane and vasculature disruption via photodynamic effect.